Literature DB >> 17376371

Pandemic flu. Clinical management of patients with an influenza-like illness during an influenza pandemic.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17376371      PMCID： PMC7133687          DOI： 10.1016/S0163-4453(07)60001-2

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  144 in total

1.  MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.

Authors:  David H Wyllie; Tim E A Peto; Derrick Crook
Journal:  BMJ       Date:  2005-09-09

2.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

Authors:  K Y Yuen; P K Chan; M Peiris; D N Tsang; T L Que; K F Shortridge; P T Cheung; W K To; E T Ho; R Sung; A F Cheng
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

3.  Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.

Authors:  E A Govorkova; I A Leneva; O G Goloubeva; K Bush; R G Webster
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

4.  Acute parotitis associated with influenza type A: a report of twelve cases.

Authors:  S J Brill; R F Gilfillan
Journal:  N Engl J Med       Date:  1977-06-16       Impact factor: 91.245

5.  Effect of influenza vaccination on disease progression among HIV-infected persons.

Authors:  P S Sullivan; D L Hanson; M S Dworkin; J L Jones; J W Ward
Journal:  AIDS       Date:  2000-12-01       Impact factor: 4.177

6.  Antistaphylococcal effect related to the area under the curve/MIC ratio in an in vitro dynamic model: predicted breakpoints versus clinically achievable values for seven fluoroquinolones.

Authors:  Alexander A Firsov; Irene Y Lubenko; Sergey N Vostrov; Yury A Portnoy; Stephen H Zinner
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

Authors:  K G Nicholson; F Y Aoki; A D Osterhaus; S Trottier; O Carewicz; C H Mercier; A Rode; N Kinnersley; P Ward
Journal:  Lancet       Date:  2000-05-27       Impact factor: 79.321

Review 8.  The impact of influenza in children.

Authors:  Flor M Munoz
Journal:  Semin Pediatr Infect Dis       Date:  2002-04

9.  Airway hyperreactivity and peripheral airway dysfunction in influenza A infection.

Authors:  J W Little; W J Hall; R G Douglas; G S Mudholkar; D M Speers; K Patel
Journal:  Am Rev Respir Dis       Date:  1978-08

10.  Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine.

Authors:  F G Hayden; S J Sperber; R B Belshe; R D Clover; A J Hay; S Pyke
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191
View more
  2 in total

1.  Triaging for adult critical care in the event of overwhelming need.

Authors:  Nigel Eastman; Barbara Philips; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2010-03-27       Impact factor: 17.440

2.  An infectious disease/fever screening radar system which stratifies higher-risk patients within ten seconds using a neural network and the fuzzy grouping method.

Authors:  Guanghao Sun; Takemi Matsui; Yukiya Hakozaki; Shigeto Abe
Journal:  J Infect       Date:  2014-12-23       Impact factor: 6.072
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.